Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

Legal questions swirl around FDA’s new expedited drug program, including who should sign off

FDA staffers and outside experts worry the program runs afoul of legal, ethical and scientific standards used to review new ...

Takeaways from the AP's report on turmoil surrounding the FDA's new fast-track drug program

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...

Some drugmakers quietly concerned about legal risk with speedy FDA review program

More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new medicines, yet other leading pharmaceutical companies are hesitating over what ...
CounterPunch

The FDA Fails to Protect Americans from the Medical Device Industry

Americans cannot rely on the Food & Drug Administration (FDA) to guarantee that medical devices are safe, and a recent Government Accountability ...
The Daily Signal

Senators Urge Admin to Reinstate Abortion Pill Regulations

Sen. Bill Cassidy criticizes a policy instituted under President Joe Biden that has made mifepristone available by mail.
Labiotech.eu

JPM 2026: what’s the outlook like this year?

This year, JPM 2026 took place again in San Francisco. Let’s look at predictions and trends forecast for 2026, according to ...

Revolution Medicines Announces FDA Breakthrough Therapy Designation for Zoldonrasib

Detailed price information for Revolution Medicines Inc (RVMD-Q) from The Globe and Mail including charting and trades.